Centuple Global

32
Sell
  • Market Cap: Micro Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: INE396H01019
  • NSEID:
  • BSEID: 531099
INR
30.22
-1.4 (-4.43%)
BSENSE

Oct 09

BSE+NSE Vol: 12.48 k

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationProfit and Loss Results
Results Snapshot
Figures in Cr
Standalone - Profit And Loss Results
Mar'26
Mar'25
Mar'24
Mar'23
Mar'22
Mar'21
Profit And Loss Analysis Highlights
stock-summary

Net Sales

YoY Growth in year ended Mar 2026 is 1,14,661.84% vs -55.75% in Mar 2025

stock-summary

Operating Profit (PBDIT) excl Other Income

YoY Growth in year ended Mar 2026 is 4,090.46% vs 89.90% in Mar 2025

stock-summary

Interest

YoY Growth in year ended Mar 2026 is -80.00% vs 150.00% in Mar 2025

stock-summary

Profit After Tax

YoY Growth in year ended Mar 2026 is 5,833.86% vs -15.89% in Mar 2025

Compare Profit and Loss Results of Centuple Global
Markets Mojo
Figures in Cr
standalone - Profit And Loss Results
Markets Mojo
Markets Mojo
Change(INR)
Change(%)
No of Months
12
12
Operating Income
573.00
4.00
569.00
14,225.00%
Less :Inter divisional transfers
0.00
0.00
0.00
0%
Less: Excise
0.00
0.00
0.00
0%
Net Sales
573.00
4.00
569.00
14,225.00%
Expenditure (Ex Depriciation)
Stock Adjustments
-1.00
-8.00
7.00
87.50%
Raw Materials Consumed
570.00
13.00
557.00
4,284.62%
Power & Fuel Cost
0.00
0.00
0.00
0%
Employee Cost
0.00
0.00
0.00
0%
Operating Expenses
0.00
0.00
0.00
0%
General and Administration Expenses
-1.00
-1.00
0.00
0.00%
Selling and Distribution Expenses
0.00
0.00
0.00
0%
Cost of Software developments
0.00
0.00
0.00
0%
Miscellaneous Expenses
0.00
0.00
0.00
0%
Expenses Capitalised
0.00
0.00
0.00
0%
Total Expenditure
571.00
5.00
566.00
11,320.00%
Operating Profit (PBDIT) excl Other Income
2.00
0.00
2.00
0%
Other Income
0.00
1.00
-1.00
-100.00%
Operating Profit (PBDIT)
2.00
0.00
2.00
0%
Interest
0.00
0.00
0.00
0%
Profit before Depriciation and Tax
2.00
0.00
2.00
0%
Depreciation
0.00
0.00
0.00
0%
Profit Before Taxation & Exceptional Items
2.00
0.00
2.00
0%
Exceptional Income / Expenses
0.00
0.00
0.00
0%
Profit Before Tax
2.00
0.00
2.00
0%
Provision for Tax
0.00
0.00
0.00
0%
Profit After Tax
1.00
0.00
1.00
0%
Extraordinary Items
0.00
0.00
0.00
0%
Adj to Profit After Tax
0.00
0.00
0.00
0%
Profit Balance B/F
-4.00
17.00
-21.00
-123.53%
Profit Available for appropriations
-3.00
18.00
-21.00
-116.67%
Appropriations
-3.00
18.00
-21.00
-116.67%
Equity Dividend (%)
0%
0%
0.00
Earnings Per Share
2.76
0.01
2.75
27,500.00%
Profit And Loss - Net Sales
Net Sales 573.81 Cr
in Mar 2026

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2026 is 1,14,661.84% vs -55.75% in Mar 2025

Profit And Loss - Operating Profit (PBDIT)
Operating Profit (PBDIT) 2.28 Cr
in Mar 2026

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2026 is 4,090.46% vs 89.90% in Mar 2025

Profit And Loss - Interest
Interest 0.00 Cr
in Mar 2026

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2026 is -80.00% vs 150.00% in Mar 2025

Profit And Loss - Profit After Tax
Profit After Tax 1.51 Cr
in Mar 2026

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2026 is 5,833.86% vs -15.89% in Mar 2025